Metastases to bone and Blood chloride decreased

Summary:

Blood chloride decreased is found among people with Metastases to bone, especially for people who are female, 60+ old.

The study analyzes which people have Blood chloride decreased with Metastases to bone. It is created by eHealthMe based on reports of 34 people who have Metastases to bone from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Metastases to bone?

Metastases to bone (cancer spreads to bone) is found to be associated with 1,127 drugs and 902 conditions by eHealthMe. Check the latest studies of Metastases to bone.

What is Blood chloride decreased?

Blood chloride decreased is found to be associated with 643 drugs and 756 conditions by eHealthMe. Check the latest studies of Blood chloride decreased.



On Jul, 19, 2026

34 people who have Metastases To Bone and Blood Chloride Decreased are studied.

Would you have Blood chloride decreased when you have Metastases to bone?

Gender of people who have Metastases To Bone and experienced Blood Chloride Decreased *:

  • female: 78.79 %
  • male: 21.21 %

Age of people who have Metastases To Bone and experienced Blood Chloride Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 33.33 %
  • 40-49: 0.0 %
  • 50-59: 24.24 %
  • 60+: 42.42 %

Common co-existing conditions for these people *:

  1. Breast Cancer: 7 people, 20.59%
  2. Lung Neoplasm Malignant (cancer tumour of lung): 4 people, 11.76%
  3. High Blood Pressure: 4 people, 11.76%
  4. Anaemia (lack of blood): 4 people, 11.76%
  5. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 5.88%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.88%
  7. Rashes (redness): 1 person, 2.94%
  8. Prostate Cancer Metastatic: 1 person, 2.94%
  9. Pain: 1 person, 2.94%
  10. Nausea (feeling of having an urge to vomit): 1 person, 2.94%

Common drugs taken by these people *:

  1. Zometa: 27 people, 79.41%
  2. Spiriva: 4 people, 11.76%
  3. Alimta: 4 people, 11.76%
  4. Advair Diskus 100/50: 4 people, 11.76%
  5. Zofran: 4 people, 11.76%
  6. Dexamethasone Sodium Phosphate: 3 people, 8.82%
  7. Innohep: 2 people, 5.88%
  8. Sandostatin Lar: 2 people, 5.88%
  9. Gemzar: 2 people, 5.88%
  10. Pamidronate Disodium: 2 people, 5.88%

Common symptoms for these people *:

  1. Weakness: 18 people, 52.94%
  2. Haemoglobin Decreased: 17 people, 50.00%
  3. Blood Sodium Decreased: 15 people, 44.12%
  4. Blood Calcium Decreased: 13 people, 38.24%
  5. Swallowing Difficulty: 10 people, 29.41%
  6. Aphonia (inability to produce voice): 10 people, 29.41%
  7. Blood Albumin Decreased: 10 people, 29.41%
  8. Platelet Count Increased: 10 people, 29.41%
  9. Blood Urea Increased: 10 people, 29.41%
  10. Dyspnea (difficult or laboured breathing): 10 people, 29.41%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Blood chloride decreased?

- Check whether Blood chloride decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Blood chloride decreased:

All the conditions that are associated with Blood chloride decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Blood chloride decreased and Metastases to bone, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: